- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 2.68M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 2.39M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 1.26M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.54M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$5M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $0 |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $7.89M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $8.56M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$1.76M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$809K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$11.07M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$7.15M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $10.45M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $10.18M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $8.4M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $9.09M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $9.36M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $10.11M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$1.33 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$6.76 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$1.33 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$6.76 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.43M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $2.34M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $1.88M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $4.97M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$3.17M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$8.5M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$3.21M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$7.31M |
| Revenue | Q1 2024 · Mar 31, 2024 | $100K |